Invention Grant
- Patent Title: Programming of cells for tolerogenic therapies
- Patent Title (中): 用于耐受性治疗的细胞编程
-
Application No.: US14185494Application Date: 2014-02-20
-
Publication No.: US09381235B2Publication Date: 2016-07-05
- Inventor: Roger Warren Sands , Eduardo Alexandre Barros e Silva , Toshihisa Kawai , David J. Mooney
- Applicant: President and Fellows of Harvard College , Forsyth Dental Infirmary for Children
- Applicant Address: US MA Cambridge US MA Cambridge
- Assignee: President and Fellows of Harvard College,Forsyth Dental Infirmary for Children
- Current Assignee: President and Fellows of Harvard College,Forsyth Dental Infirmary for Children
- Current Assignee Address: US MA Cambridge US MA Cambridge
- Agency: Mintz Levin Cohn Ferris Glovsky and Popeo, P.C.
- Agent Ingrid A. Beattie
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K39/35 ; A61K39/39 ; A61K39/102

Abstract:
Biomaterial systems, e.g., gel scaffolds, are used in vivo to recruit immune cells and promote their activation towards a non-inflammatory phenotype, thereby leading suppression of inflammation. The compositions and methods are useful to reduce the severity of autoimmunity, chronic inflammation, allergy, and periodontal disease.
Public/Granted literature
- US20140234423A1 PROGRAMMING OF CELLS FOR TOLEROGENIC THERAPIES Public/Granted day:2014-08-21
Information query